Chimagen Biosciences
PrivateLast Round
M&A
Oct 29, 2024
Company Overview
Chimagen Biosciences is a clinical-stage biotechnology company that discovers and develops multi-specific T cell-engagers and NK cell-engagers for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chimagen Biosciences Comparables
Compare Chimagen Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innovent Biologics | 82% | |
| Harbour BioMed | 79% | |
| AstraZeneca | 78% |
Chimagen Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Oct 29, 2024 | ||||
| Series B | Oct 1, 2024 |
Chimagen Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foresite Capital | Series B |
| Lilly Asia Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
$300M round led by GSK plc.
Chimagen Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Chimagen Biosciences's valuation, stock price, and market status.
Is Chimagen Biosciences a public or private company?
Chimagen Biosciences is a private company.
What is the current stock price of Chimagen Biosciences?
Chimagen Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Chimagen Biosciences worth (valuation)?
Valuation information for Chimagen Biosciences is not publicly available.
Can I buy Chimagen Biosciences stock?
Chimagen Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Chimagen Biosciences's last funding round?
Chimagen Biosciences's most recent funding round was M&A on October 29, 2024.
Who are the main investors in Chimagen Biosciences?
Key investors in Chimagen Biosciences include Foresite Capital, Lilly Asia Ventures.
Will Chimagen Biosciences IPO soon?
No public IPO plans have been announced for Chimagen Biosciences.
How can I track Chimagen Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Chimagen Biosciences's secondary market activity and sign up for updates.